Tehran, Iran | 23–25 October 2024
The workshop focused on the introduction of eukaryotic genome editing technologies, novel approaches to cancer treatment, and gene transfer using CRISPR (CRISPR/Cas9).
Particular appreciation for the outstanding presentations and posters at the second international Cancer Genomics Congress
The Idea to Startup Festival, organized by the Commercialization Committee of the International Congress of Cancer Genomics and centered on the Amper Innovation Factory, is ready to receive and support your innovative cancer-related ideas and initiatives
Dear Visitors, I warmly welcome you on behalf of The 2nd International Congress of Cancer Genomics (CGC2024). As the Social Responsibility Committee Secretary, I am honored to have this opportunity to address you. Our congress is not just a platform for scientific discussions and discoveries; it is a testament to the profound impact of these […]
Cancer is not a disease; it is a collection of pain and sufferings. Cancer does not only bring pain and suffering to the one who is dealing with it, but their family and those around them also take part in it. This disease has ensnared humans thousands of years ago, but in all these long […]
The first International Cancer Genomics Congress (CGC2023) was held in May 2023 at the Iran International Conference Center. The congress was organized by a consortium of national scientific societies in collaboration with the Italian Society of Biophysics and Molecular Biology (SIBBM). In the first congress, we successfully established the necessary infrastructure for the Cancer Genomics […]
The first International Cancer Genomics Congress (CGC2023) was a unique experience of holding a 4th-generation scientific conference. Along with the evolution of the world’s universities from a teaching-oriented university (first generation) to a research-oriented one (second generation), and then an entrepreneurial university (third generation) and a socially responsible university (fourth generation), Cancer Genomics Congress was […]
